UK markets close in 6 hours 36 minutes

BenevolentAI S.A. (2XA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6600+0.0100 (+1.54%)
As of 09:59AM CET. Market open.
Full screen
Previous close0.6500
Open0.6450
Bid0.0000 x N/A
Ask0.7200 x N/A
Day's range0.6450 - 0.6600
52-week range0.4460 - 2.5000
Volume344
Avg. volume282
Market cap85.921M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-55.7400
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers

    LONDON, March 25, 2024--Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today announces positive safety data from its Phase Ia, first-in-human, clinical study of BEN-8744 in healthy volunteers.

  • Business Wire

    BenevolentAI Appoints New Chief Technology Officer

    LONDON, March 20, 2024--BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today announces that the current Chief Technology Officer (CTO), Dr. Daniel Neil, is leaving the Company at the beginning of April after 7 years at BenevolentAI to relocate to be nearer his family. The Company is pleased to announce the appointment of Dr. James Malone as BenevolentAI’s new Chief Technology Officer. James will j

  • Business Wire

    BenevolentAI: Publication of 2023 Annual Report and 2024 AGM Notice

    LONDON, March 20, 2024--Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today announces the publication of its Annual Report and Accounts for the year ended 31 December 2023 (the "2023 Annual Report") and the convening notice for its annual general meeting to be held on 2 May 2024 at 14:00 CEST at 2, place Winston Churchill, L-1340 Luxembourg (the "2024 AGM") (the "2024 AGM Notice"